Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial

BACKGROUND: Sparse data on the safety of pyronaridine-artesunate after repeated treatment of malaria episodes restrict its clinical use. We therefore compared the safety of pyronaridine-artesunate after treatment of the first episode of malaria versus re-treatment in a substudy analysis. METHODS: Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Sagara, Issaka, Beavogui, Abdoul Habib, Zongo, Issaka, Soulama, Issiaka, Borghini-Fuhrer, Isabelle, Fofana, Bakary, Camara, Daouda, Somé, Anyirékun F, Coulibaly, Aboubacar S, Traore, Oumar B, Dara, Niawanlou, Kabore, Moïse J T, Thera, Ismaila, Compaore, Yves D, Sylla, Malick Minkael, Nikiema, Frederic, Diallo, Mamadou Saliou, Dicko, Alassane, Gil, Jose Pedro, Borrmann, Steffen, Duparc, Stephan, Miller, Robert M, Doumbo, Ogobara K, Shin, Jangsik, Bjorkman, Anders, Ouedraogo, Jean-Bosco, Sirima, Sodiomon B, Djimdé, Abdoulaye A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science ;, The Lancet Pub. Group 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726763/
https://www.ncbi.nlm.nih.gov/pubmed/26601738
http://dx.doi.org/10.1016/S1473-3099(15)00318-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726763/
https://www.ncbi.nlm.nih.gov/pubmed/26601738
http://dx.doi.org/10.1016/S1473-3099(15)00318-7

Ejemplares similares